Health and Healthcare

Moderna : MRNA

All Moderna Articles

124 Articles

Jon C. Ogg | Sep 8, 2020 at 3:27 PM EDT

What Does a Perfect COVID-19 Vaccine Actually Mean?

The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead…

Jon C. Ogg | Sep 8, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

Tuesday's top analyst upgrades and downgrades include Apple, Baidu, Boeing, Delta Air Lines, L3Harris Technologies, Moderna, Raytheon Technologies, Roku and…

Jon C. Ogg | Sep 2, 2020 at 7:27 PM EDT

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

America and the rest of the world is getting ready for a vaccine that will help protect public health against…

Jon C. Ogg | Sep 1, 2020 at 8:46 AM EDT

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…

Jon C. Ogg | Aug 26, 2020 at 11:21 AM EDT

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Independent research firm Argus has reiterated its Buy rating on Moderna and is calling this large pullback a buying opportunity.

Chris Lange | Aug 12, 2020 at 11:28 AM EDT

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of…

Jon C. Ogg | Aug 6, 2020 at 9:12 AM EDT

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Thursday's top analyst upgrades and downgrades included Costco, Enphase Energy, Etsy, Moderna, Novavax, Regeneron Pharmaceuticals, Roku, Square, Teva Pharmaceutical, Wayfair…

Chris Lange | Jul 24, 2020 at 11:25 AM EDT

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute…

Jon C. Ogg | Jul 23, 2020 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Apache, Check Point, Chipotle, EA, Inogen, Microsoft, Moderna, Shopify, Tesla, Varonis and More

Thursday's top analyst upgrades and downgrades included Apache, Check Point Software Technologies, Chipotle Mexican Grill, Electronic Arts, Inogen, Microsoft, Moderna,…

Lee Jackson | Jul 22, 2020 at 7:28 AM EDT

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

These four top Jefferies growth stock picks all offer investors strength in their specific industries and the ability to generate…

Jon C. Ogg | Jul 20, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with…

Chris Lange | Jul 17, 2020 at 7:44 AM EDT

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street…

Chris Lange | Jul 15, 2020 at 10:31 AM EDT

Moderna’s Next Big Step in the Race to a COVID-19 Vaccine

Moderna made another big step forward in the fight against COVID-19 after the company reported incredibly positive data from the…

Chris Lange | Jul 13, 2020 at 11:31 AM EDT

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus…

Jon C. Ogg | Jul 13, 2020 at 9:08 AM EDT

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Apple, Disney, DuPont, Halliburton, Moderna, Phillips 66, Sunrun, Teladoc and More

Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Apple, Disney, DuPont, Halliburton, Moderna, Phillips 66, Sunrun, Teladoc and more.

1 … 5 6 7 8 9

Moderna : MRNA

All Moderna Articles

What Does a Perfect COVID-19 Vaccine Actually Mean?

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Top Analyst Upgrades and Downgrades: Apache, Check Point, Chipotle, EA, Inogen, Microsoft, Moderna, Shopify, Tesla, Varonis and More

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

Moderna’s Next Big Step in the Race to a COVID-19 Vaccine

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Apple, Disney, DuPont, Halliburton, Moderna, Phillips 66, Sunrun, Teladoc and More

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Moderna : MRNA

All Moderna Articles

What Does a Perfect COVID-19 Vaccine Actually Mean?

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Top Analyst Upgrades and Downgrades: Apache, Check Point, Chipotle, EA, Inogen, Microsoft, Moderna, Shopify, Tesla, Varonis and More

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

Moderna’s Next Big Step in the Race to a COVID-19 Vaccine

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Apple, Disney, DuPont, Halliburton, Moderna, Phillips 66, Sunrun, Teladoc and More

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026